Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Clinical electroencephalographic criteria for the efficacy of rispolept therapy in children with Tourette's syndrome

Full Text:


To develop the clinical and electroencephalographic criteria for the efficiency of rispolept in children with Tourette's syndrome, the authors analyze the results of treatment in 15 patients aged 8-15 years who took rispolept in a dose of 2-3 mg/day. The clinical and electroencephalographic assessment of the therapy for tick hyperkinesis revealed a significant reduction in the frequency of ticks, a decrease in the number of hyperkinesis tests, and normalization of bioelectrical rhythms in the brain sensomotor regions. The use of rispolept caused positive changes on treatment day 15; its adverse reactions were noted rarely and required no drug discontinuance.


1. <div><p>Зыков В.П. Лечение тиков и синдрома Туретта у детей. Альманах «Исцеление». М., 2000; 4: 181-3.</p><p>Гузева В.И., Чутко Л.С., Катышева Н.В. и др. Лечение тикозных гиперкинезов у детей с помощью метода биоуправления. Рос. вестн. перинатол. и педиатр. 1996; 41(2): 25.</p><p>Пелехова О.Л. Современные подходы к диагностике и лечению тиков и тикоподобных гиперкинезов. Экспер. и клин. мед. 1999; 1: 63-5.</p><p>Чутко Л. С. Клиническая оценка и лечение тикозных гиперкинезов. Автореф. дис. ... канд. мед. наук. СПб., 1996; 23.</p><p>Jancovic J. Tourette's syndrome. N Engl J Med 2001; 345(16): 1184-92.</p><p>Sindo J., Jorgenson J.I. Treatment of tics in Tourette syndrome with atypical antipsychotic drugs. Ugeskr Laeger 2002; 164(32): 3755-9.</p><p>Zimenes-Zimenes F.J., Garsia-Ruiz P.J. Pharmacological options for the treatment of Tourette's disorder. Drugs 2001; 61(15): 2207-20.</p><p>Калинин В.В. К проблеме отграничения новых нейролептиков от классических. Сопоставление клинического и нейрохимического подхода. Психиатр. и психофармакотер. 2001; 3(4): 129-31.</p><p>Benkelfat C., Murphy D., Zonar J. et al. Clomipramine in Clomipramine: further evidence for a serotonergic mechanism of action. Arch Gen Psychiat 1989; 46: 23-8.</p><p>Casey D.E. Paradoxical tardive dyskinesia. In: Disorders of Movement in Psychiatry and Neurology. Cambridge: Blackwell, 1992; 67-9.</p><p>Dion Y., Annable L., Sandor P., Chouinard G. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002; 22(1): 31-9.</p><p>Fortaine K., Choninard G. An open clinical trial of fluoxetine in the treatment of obsessive- compulsive disorder. J Clin Psychopharmacol 1986; 6: 98-101.</p><p>Czobor P., Volavka J., Sheilman B. et al. Antipsychotic-induced weight gain and therapeutic response: a differential association. J Clin Psychopharmacol 2002; 22: 244-51.</p><p>Manos M.J., Short E.J., Findling R.L. Differential effectiveness of methylphenidate and Adderall in school-age youths with attention- deficit/ hyperactivity disorder J Am Acad Child Adolesc Psychiatry 1999; 38(7): 813-9.</p><p>Klett C., Caffey E. Weight changes during treatment with phenothiazine derivatives. J Neuropshychiar 1960; 2: 102-8.</p><p>Planansky K., Heilizer F. Weight changes in relation to the characteristic of patients on chlorpromazine. J Clin Exp Psychopathol Q Rev Psychiat Neurol 1959; 20: 53-7.</p><p>Дахаева Л.Н. Компьютерное нейрокартирование головного мозга при синдроме Жиль де ла Туретта у детей. Автореф. дис. ... канд. мед. наук. М., 1998; 9-10,19.</p><p>Keck P.E. Jr., McElroy S.L., Arnold L.M. Ziprasidone: a new atypical antipsychotic. Expert Opin Pharmacother 2001; 2(6): 1033-42.</p></div><br />

For citation:

Zykov V.P., Kabanova S.A. Clinical electroencephalographic criteria for the efficacy of rispolept therapy in children with Tourette's syndrome. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(2):46-49. (In Russ.)

Views: 370

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)